Funding
Researcher : Manuel García de Yébenes Castro
4 funding - 422,650€
2023
-
Investigating thransthyretin amyloid cardiomyopathy through advanced disease modeling
euro 162,500.00
-
Targeted NANOmedicine to reverse FIBrosis in ischemic cardiomyopathies
euro 124,630.00
-
Cribado CRISPR funcional para identificar nuevas dianas epigenéticas mediadoras de la transformación fibrótica en el remodelado cardiaco adverso
euro 135,520.00